• Join
  • Login
  • Contact

Search abstracts

Extended-release OROS hydromorphone long-term follow up in patient with chronic pain

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Poster
  • By: YAO, Man-Lih (MacKay Memorial Hospital, pharmacy, Taipei, China Taiwan)
  • Co-author(s): Man-Lih Yao:pharmacy,MacKay Memorial Hospital,Taipei,Taiwan, Province of China|Chien-Hsien Lin:pharmacy,MacKay Memorial Hospital,Taipei,Taiwan, Province of China|Chih-Fang Chen:pharmacy,MacKay Memorial Hospital,Taipei,Taiwan, Province of China|Wei-Ying Lee:pharmacy,MacKay Memorial Hospital,Taipei,Taiwan, Province of China|Ling-Chu Wang:Pharmacy,MacKay Memerial Hospital,Taipei,Taiwan, Province of China
  • Abstract:

    In contrast to immediate-release hydromorphone, extended-release OROS hydromorphone (Jurnista®) produces relatively constant steady-state concentrations for 24 hours. But twice-daily use were found be prescribed in outpatient clinic. 

    The study retrospect review past computerized record with Brio-query Software since Oct. 2014 to Aug. 2015. All


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses